Concepedia

Ussama Al Homsi

UA

Statistics

Publications

4

Citations

131

H-Index

4

Active since

2001

Affiliations

Hamad Medical Corporation(Current)

National Center for Cancer Care and Research

Hamad bin Khalifa University

Qatar University

Ussama Al Homsi is an author at Hamad Medical Corporation specializing in oncology, immune checkpoint inhibitor biomarkers, and cancer immunology.

Publications per year

2001–2023

4

Publications

4

Circulating exosomal immuno-oncological checkpoints and cytokines are potential biomarkers to monitor tumor response to anti-PD-1/PD-L1 therapy in non-small cell lung cancer patients

Shayista Akbar, Afsheen Raza, Reyad Mohsin et al. · Frontiers in Immunology · 2023 · 51 citations · Full text

Life Sciences, Immunology, Oncology +17

Double-blind, placebo-controlled cross-over study of oral pilocarpine for the prevention of chemotherapy-induced oral mucositis in adult patients with cancer

Abdalla Awidi, Ussama Al Homsi, R.I Kakail et al. · European Journal of Cancer · 2001 · 43 citations

Pharmacy, Oncology, Pharmacotherapy +17

The effect of protein mutations on drug binding suggests ensuing personalised drug selection

Shunzhou Wan, Deepak Kumar, Valentin Ilyin et al. · Scientific Reports · 2021 · 23 citations · Full text

Medicine, Bioinformatics, Pharmacology +17

Serum immune mediators as novel predictors of response to anti-PD-1/PD-L1 therapy in non-small cell lung cancer patients with high tissue-PD-L1 expression

Afsheen Raza, Reyad Mohsen, Aladdin Kanbour et al. · Frontiers in Immunology · 2023 · 14 citations · Full text

Medicine, Immunology, Oncology +17

1–4 of 4